Internal ribosomal entry-site activities of clinical isolate-derived hepatitis A virus and inhibitory effects of amantadine

Hepatology Research

Volumn 40, Issue 4, 2010, Pages 415-423

  Kanda, Tatsuo ^a   Imazeki, Fumio ^a   Nakamoto, Shingo ^a   Okitsu, Kohichiroh ^a   Fujiwara, Keiichi ^a   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Amantadine; Fulminant hepatitis; Hepatitis A virus; Hepatocyte; Internal ribosomal entry site

Indexed keywords

AMANTADINE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; HUMAN CELL; INTERNAL RIBOSOME ENTRY SITE; LIVER CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL;

EID: 77954376648     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2010.00617.x     Document Type: Article

References (34)

1. Martin A, Lemon SM. Hepatitis A virus: from discovery to vaccines. Hepatology 2006, 43:S164-S172.
2. Pinto RM, Aragones L, Costafreda MI, Ribes E, Bosch A. Codon usage and replicative strategies of hepatitis A virus. Virus Res 2007, 127:158-63.
3. Daniels D, Grytdal S, Wasley A. Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveil Summ 2009, 58:1-27.
4. Hernandez B, Hasson NK, Cheung R. Hepatitis C performance measure on hepatitis A and B vaccination: missed opportunities? Am J Gastroenterol 2009, 104:1961-7.
5. Kanda T, Kusov Y, Yokosuka O, Gauss-Müller V. Interference of hepatitis A virus replication by small interfering RNAs. Biochem Biophys Res Commun 2004, 318:341-5.
6. Kanda T, Zhang B, Kusov Y, Yokosuka O, Gauss-Müller V. Suppression of hepatitis A virus genome translation and replication by siRNAs targeting the internal ribosomal entry site. Biochem Biophys Res Commun 2005, 330:1217-23.
7. Kanda T, Yokosuka O, Imazeki F, Fujiwara K, Nagao K, Saisho H. Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells. Biochem Biophys Res Commun 2005, 331:621-9.
8. Kusov Y, Kanda T, Palmenberg A, Sgro JY, Gauss-Müller V. Silencing of hepatitis A virus infection by small interfering RNAs. J Virol 2006, 80:5599-610.
9. El-Sabbagh OI, Rady HM. Synthesis of new acridines and hydrazones derived from cyclic b-diketone for cytotoxic and antiviral evaluation. Eur J Med Chem 2009, 44:3680-6.
10. Radha Krishna Y, Saraswat VA, Das K. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis. Liver Int 2009, 29:392-8.
11. Schultz DE, Honda M, Whetter LE, Mcknight KL, Lemon SM. Mutations within the 5' nontranslated RNA of cell culture-adapted hepatitis A virus which enhance cap-independent translation in cultured African green monkey kidney cells. J Virol 1996, 70:1041-9.
12. Brown EA, Zajac AJ, Lemon SM. In vitro characterization of an internal ribosomal entry site (IRES) present within the 5' nontranslated region of hepatitis A virus RNA: comparison with the IRES of encephalomyocarditis virus. J Virol 1994, 68:1066-74.
13. Cohen JI, Ticehurst JR, Purcell RH, Buckler-White A, Baroudy BM. Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol 1987, 61:50-9.
14. Lemon SM, Binn LN, Marchwicki R. In vivo replication and reversion to wild type of a neutralization-resistant antigenic variant of hepatitis A virus. J Infect Dis 1990, 161:7-13.
15. Totsuka A, Moritsugu Y. Hepatitis A virus protein. Intervirology 1999, 42:63-8.
16. Widell A, Hansson BG, Oberg B, Nordenfelt E. Influence of twenty potentially antiviral substances on in vitro multiplication of hepatitis A virus. Antiviral Res 1986, 6:103-12.
17. Crance JM, Biziagos E, Passagot J, van Cuyck-Gandre H, Deloince R. Inhibition of hepatitis A virus replication in vitro by antiviral compounds. J Med Virol 1990, 31:155-60.
18. Crance JM, Leveque F, Chousterman S, Jouan A, Trepo C, Deloince R. Antiviral activity of recombinant interferon-alpha on hepatitis A virus replication in human liver cells. Antiviral Res 1995, 28:69-80.
19. Emerson SU, Lewis M, Govindarajan S, Shapiro M, Moskal T, Purcell RH. cDNA clone of hepatitis A virus encoding a virulent virus: induction of viral hepatitis by direct nucleic acid transfection of Marmosets. J Virol 1992, 66:6649-54.
20. Fujiwara K, Yokosuka O, Ehata T. Frequent detection of hepatitis A viral RNA in serum during the early convalescent phase of acute hepatitis A. Hepatology 1997, 26:1634-9.
21. Fujiwara K, Yokosuka O, Ehata T. Association between severity of type A hepatitis and nucleotide variations in the 5' non-translated region of hepatitis A virus RNA strains from fulminant hepatitis have fewer nucleotide substitutions. Gut 2002, 51:82-8.
22. Jansen RW, Siegl G, Lemon SM. Molecular epidemiology of human hepatitis A virus defined by an antigen-capture polymerase chain reaction method. Proc Natl Acad Sci USA 1990, 87:2867-71.
23. Robertson BH, Jansen RW, Khanna B. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol 1992, 73:1365-77.
24. Kanda T, Yokosuka O, Ehata T. Detection of GBV-C RNA in patients with non-A-E fulminant hepatitis by reverse-transcription polymerase chain reaction. Hepatology 1997, 25:1261-5.
25. Brown EA, Day SP, Jansen RW, Lemon SM. The 5' nontranslated region of hepatitis virus RNA: Secondary structure and elements required for translation in vitro. J Virol 1991, 65:5828-38.
26. Glass MJ, Jia X-Y, Summers DF. Identification of the hepatitis A virus internal ribosome entry site: In vivo and in vitro analysis of bicistronic RNAs containing the HAV 5' noncoding region. Virology 1993, 193:842-52.
27. Gauss-Müller V, Kusov YY. Replication of hepatitis A virus replicon detected by genetic recombination in vivo. J Gen Virol 2002, 83:2183-92.
28. Ashida M, Hamada C. Molecular cloning of the hepatitis A virus receptor from a simian cell line. J Gen Virol 2002, 78:1565-9.
29. Kiernan RE, Marshall JA, Coulepis AG, Anderson DA, Gust ID. Cellular changes associated with persistent hepatitis A infection in vitro. Arch Virol 1987, 94:81-95.
30. Tsarev SA, Emerson SU, Balayan MS, Ticehurst J, Simian Purcell RH. Hepatitis A virus (HAV) strain AGM-27: comparison of genome structure and growth in cell culture with other HAV strains. J Gen Virol 1991, 72:1677-83.
31. Chitambar S, Joshi M, Lole K, Walimbe A, Vaidya S. Cocirculation of and coinfections with hepatitis A virus subgenotypes IIIA and IB in patients from Pune, western India. Hepatol Res 2007, 37:85-93.
32. Fujiwara K, Yokosuka O, Imazeki F, Saisho H, Miki M, Omata M. Do high levels of viral replication contribute to fulminant hepatitis A? Liver Int 2005, 25:194-5.
33. Tami C, Silberstein E, Manangeeswaran M. Immunoglobulin A (IgA) is a natural ligand of hepatitis A virus cellular receptor 1 (HAVCR1), and the association of IgA with HAVCR1 enhances virus-receptor interactions. J Virol 2007, 81:3437-46.
34. Konduru K, Virata-Theimer ML, Yu MY, Kaplan GG. A simple and rapid hepatitis A virus (HAV) titration assay based on antibiotic resistance of infected cells: evaluation of the HAV neutralization potency of human immune globulin preparations. Virol J 2008, 5:155.